Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Cosmos Health (COSM) Non Operating Investment Income (2018 - 2025)

Cosmos Health (COSM) has disclosed Non Operating Investment Income for 4 consecutive years, with $428.0 as the latest value for Q3 2024.

  • For the quarter ending Q3 2024, Non Operating Investment Income rose 139.16% year-over-year to $428.0, compared with a TTM value of $1425.0 through Sep 2024, down 68.71%, and an annual FY2018 reading of $2.5 million, changed N/A over the prior year.
  • Non Operating Investment Income was $428.0 for Q3 2024 at Cosmos Health, up from $335.0 in the prior quarter.
  • Across five years, Non Operating Investment Income topped out at $2676.0 in Q2 2023 and bottomed at -$1093.0 in Q3 2023.
  • Average Non Operating Investment Income over 3 years is $1010.3, with a median of $1293.0 recorded in 2023.
  • Peak annual rise in Non Operating Investment Income hit 139.16% in 2024, while the deepest fall reached 87.48% in 2024.
  • Year by year, Non Operating Investment Income stood at $1678.0 in 2022, then plummeted by 165.14% to -$1093.0 in 2023, then skyrocketed by 139.16% to $428.0 in 2024.
  • Business Quant data shows Non Operating Investment Income for COSM at $428.0 in Q3 2024, $335.0 in Q2 2024, and $1755.0 in Q1 2024.